AI-generated summary
In a rat model of hepatic encephalopathy, the authors compared intracranial methylene blue with transcranial red light therapy, both aimed at the mitochondrial enzyme cytochrome c-oxidase. The authors report that both treatments improved memory deficits, with different effects on enzyme activity across brain regions. The study used animals rather than people, and its findings are therefore preliminary.
- Who or what was studied
- Rats in a hepatic encephalopathy animal model, in five groups of 6 or 7 animals
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study used a small animal sample and a rat model, so results may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 9 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Cytochrome c oxidase, Sham, Transcranial photobiomodulation, Light-emitting diode, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.